Thursday, September 4, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity

July 16, 2024
in Cancer
Reading Time: 4 mins read
0
Oncotarget
66
SHARES
602
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

“[…] we found an independent positive prognostic effect of HER2-low compared to HER2-zero in early breast cancer.”

Oncotarget

Credit: 2024 Schmidt et al.

“[…] we found an independent positive prognostic effect of HER2-low compared to HER2-zero in early breast cancer.”

BUFFALO, NY- July 16, 2024 – A new editorial paper was published in Oncotarget’s Volume 15 on June 20, 2024, entitled, “HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity.”

In this new editorial, researchers Marcus Schmidt, Hans-Anton Lehr, and Katrin Almstedt from the University Medical Center of Johannes Gutenberg University discuss HER2 in breast cancer. HER2 is a well-established prognostic and predictive factor in breast cancer, which is associated with a poor prognosis but also offers the chance of improved survival when treated with targeted therapies based on the monoclonal antibody trastuzumab, both in advanced (hazard ratio (HR) 0.82, 95% confidence interval (CI) 0.71 to 0.94, P = 0.004) and in early (HR 0.66, 95% CI 0.57 to 0.77, P < 0.00001) stages. 

The American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) defines HER2-positivity as either 3+ by immunohistochemistry (IHC) or 2+ with amplification by in situ hybridization (ISH). Yet, the vast majority of breast tumors are considered HER2- negative (IHC 0 or 1+ or 2+ without amplification) by these criteria, and it has until recently been accepted that HER2-negative tumors do not benefit from trastuzumab based therapy. 

“Now, results of randomized trials with trastuzumab-based antibody-drug conjugates (ADCs) such as trastuzumab deruxtecan (T-DXd) have fundamentally challenged this long-held view.”
 

Continue reading: DOI:

Correspondence to:  Marcus Schmidt

Email: marcus.schmidt@unimedizin-mainz.de 

Keywords: breast cancer, HER2, HER2-low, prognostic, predictive

Click here to sign up for free Altmetric alerts about this article.
 

About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:

  • X, formerly Twitter
  • Facebook
  • YouTube
  • Instagram
  • LinkedIn
  • Pinterest
  • Reddit
  • Spotify, and available wherever you listen to podcasts

 

Click here to subscribe to Oncotarget publication updates.

For media inquiries, please contact media@impactjournals.com.

 

Oncotarget Journal Office

6666 East Quaker Street., Suite 1

Orchard Park, NY 14127

Phone: 1-800-922-0957 (option 2)

###



Journal

Oncotarget

DOI

10.18632/oncotarget.28598

Method of Research

Observational study

Subject of Research

People

Article Title

HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity

Article Publication Date

20-Jun-2024

Share26Tweet17
Previous Post

Advancing quantum research – DOE inks MOU with Department of Defense

Next Post

SwRI, UTD jointly fund project to evaluate space sensor in unique facility

Related Posts

blank
Cancer

High-Throughput Antibody Testing Platform Poised to Accelerate Disease Research and Therapeutic Advances

September 3, 2025
blank
Cancer

4D-Printed Microdevices Detect Pancreatic Cancer Biomarkers

September 3, 2025
blank
Cancer

New Study Uncovers Connection Between Excessive Alcohol Consumption and Fatty Liver Disease

September 3, 2025
blank
Cancer

Colorectal Cancer Exhibits Distinct Microbial Signature, DNA Analysis Reveals

September 3, 2025
blank
Cancer

Sugar-coated nanoparticles show promise in targeting deadly breast cancer

September 3, 2025
blank
Cancer

SERAPHINA Study: Nab-Paclitaxel Benefits in HER2-Negative Cancer

September 3, 2025
Next Post
MOLECULAR BEAM FACILITY

SwRI, UTD jointly fund project to evaluate space sensor in unique facility

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27544 shares
    Share 11014 Tweet 6884
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    958 shares
    Share 383 Tweet 240
  • Bee body mass, pathogens and local climate influence heat tolerance

    643 shares
    Share 257 Tweet 161
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    510 shares
    Share 204 Tweet 128
  • Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn

    313 shares
    Share 125 Tweet 78
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • How Age and Gender Influence Expressive Flexibility’s Mental Health Impact
  • Exploring STEM/STEAM Training for Science Teachers in Colombia
  • Achieving Carbon Neutrality: Balancing Growth and Green Innovations
  • Brain-Wide Neural Activity Map Reveals Behavior

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,183 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading